Literature DB >> 7504059

Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.

G J Freeman1, F Borriello, R J Hodes, H Reiser, J G Gribben, J W Ng, J Kim, J M Goldberg, K Hathcock, G Laszlo.   

Abstract

The B7-1 molecule, expressed on antigen presenting cells (APC), provides a crucial costimulatory signal for T cell activation. Recent studies demonstrate the existence of alternative, non-B7-1 CTLA4 counter-receptors in mice and humans. Here, we describe the molecular cloning and demonstrate costimulatory function of the murine B7-2 (mB7-2) gene. Murine B7-2 cDNA encodes a member of the Ig supergene family that binds CTLA4-Ig and stains with the GL1 but not anti-mB7-1 mAb. Murine B7-2 costimulates the proliferation and interleukin 2 production of CD4+ T cells and this costimulation can be inhibited by either CTLA4-Ig or GL1 mAb. Identification of the B7-2 molecule will permit further manipulation of the B7:CD28/CTLA4 costimulatory pathway which has been shown to be involved in the prevention of tolerance, induction of tumor immunity, and most recently, in the pathogenesis of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504059      PMCID: PMC2191273          DOI: 10.1084/jem.178.6.2185

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

Review 1.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

Authors:  D L Mueller; M K Jenkins; R H Schwartz
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

Authors:  P S Linsley; E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 4.  Role of the CD28 receptor in T-cell activation.

Authors:  C H June; J A Ledbetter; P S Linsley; C B Thompson
Journal:  Immunol Today       Date:  1990-06

5.  Costimulatory requirements of murine Th1 clones. The role of accessory cell-derived signals in responses to anti-CD3 antibody.

Authors:  I R Williams; E R Unanue
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

6.  Costimulatory signal provided by a B-lymphoblastoid cell line and its Ia-negative variant.

Authors:  H Reiser; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

Authors:  G J Freeman; A S Freedman; J M Segil; G Lee; J F Whitman; L M Nadler
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

Review 8.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

9.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

10.  Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells.

Authors:  K Kawakami; Y Yamamoto; K Kakimoto; K Onoue
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

View more
  72 in total

Review 1.  The molecular basis of T cell differentiation.

Authors:  R A Flavell
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma.

Authors:  Cristan Herbert; Melissa M Scott; Kim H Scruton; Rylie P Keogh; Kristy C Yuan; Kenneth Hsu; Jessica S Siegle; Nicodemus Tedla; Paul S Foster; Rakesh K Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.

Authors:  Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

Review 4.  CD28/B7 regulation of autoimmune diabetes.

Authors:  K G Herold; D J Lenschow; J A Bluestone
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

5.  Extending the B7 (CD80) gene family.

Authors:  P S Linsley; R Peach; P Gladstone; J Bajorath
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

6.  Cloning and sequencing of the rabbit gene encoding T-cell costimulatory molecules.

Authors:  T Isono; A Seto
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 7.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

8.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Authors:  M K Racke; D E Scott; L Quigley; G S Gray; R Abe; C H June; P J Perrin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes.

Authors:  Christopher R Lucas; Hector M Cordero-Nieves; Robert S Erbe; Jaclyn W McAlees; Sumeena Bhatia; Richard J Hodes; Kerry S Campbell; Virginia M Sanders
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

10.  B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer.

Authors:  Penghui Zhou; Xincheng Zheng; Huiming Zhang; Yang Liu; Pan Zheng
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.